Mendus

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With C Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma	Phase 1	2019-01-14
Unknown	Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Acute Myeloid Leukemia in Remission	Phase 2	2018-10-15
Completed	A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Strom Gastrointestinal Stromal Tumor	Phase 1	2016-06-01
Completed	Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post Renal Cell Carcinoma, Metastatic	Phase 2	2015-04-01
Completed	Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma Hepatocellular Carcinoma	Phase 1	2013-10-01
Completed	A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Metastatic Renal Cell Carcinoma	Phase 1	2012-02-01
Completed	Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia (AML), Leukemic Dendritic Cell Vaccination	Phase 1 / Phase 2	2011-04-01